Milla Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MILLA PHARMS
MILLA PHARMS has ten approved drugs.
Summary for Milla Pharms
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 10 |
Drugs and US Patents for Milla Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Milla Pharms | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 217308-002 | Jun 7, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Milla Pharms | TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 212676-001 | Jul 17, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Milla Pharms | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 211081-002 | Jul 17, 2020 | AP1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Milla Pharms | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 207848-002 | Jan 13, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
